Contract Awarded

SURGICAL INNOVATIONS GROUP PLC 7 October 1999 SURGICAL INNOVATIONS WIN £170,000 CONTRACT IN TURKEY FOR AUTOLOGOUS BLOOD PRODUCTS Surgical Innovations also takes gold in top industry awards Surgical Innovations Group plc, the Aim listed provider of healthcare products primarily for the operating theatre, today announces that it has secured a contract to supply its autologous blood products to Turkish distributor Mikromed, which specialises in this field. Orders for staged deliveries over the next 12 months have been agreed in excess of £170,000. Commenting on the new deal, Ian Lomas Managing Director said: 'This new deal clearly shows that previous production delays relating to the autologous blood products are now being overcome.' He continued: 'Turkey has an advanced medical market, which is difficult to enter and this deal is a great endorsement for our products.' Following initial discussions with Surgical Innovations the Turkish distributor carried out market research to assess the demand for autologous blood products in its country and found it to be considerable. The majority of the order is to supply the Intra-operative system (Haemocell ABT), although the distributor will carry the full range of blood products. A further market research study is now underway to assess the opportunity for the company's keyhole surgery devices. Surgical Innovations has also won the Gold Award at the PRW awards for excellence for its new F4 product. The F4 is a new handle design for keyhole surgery instruments. The awards are held only every three years and Surgical Innovations beat hundreds of nominations from a broad spectrum of industries. Previous winners of the Gold Award, such as Glaxo Wellcome's multi-dose powder inhaler, have gone on to become market leaders in their field. The F4 has been under development for 2.5 years and is set to become the next leading product for Surgical Innovations. It is due to be launched in the Autumn, although an order has already been secured for the handle sets from a US instrument company. Ian Lomas commented: 'Surgical Innovations prides itself on being at the leading edge of technology for keyhole surgery. We have always placed great emphasis on R&D and an award like this shows the value of that investment.' For further information contact: Surgical Innovations Group plc Citigate Dewe Rogerson Ian Lomas Keeley Middleton Tel: 0113 230 7597 Tel: 0113 297 9899
UK 100

Latest directors dealings